CD8+CD39+CCR7low cells were almost undetectable in the blood of individuals with BrM and glioma, while among TILs, we found a significantly higher proportion in BrM than in glioma (Fig. 3b). The gene discussed is CD8A; the disease is central nervous system cancer.